# A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

> **NCT05579925** · PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 24 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT05579925
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-07
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05579925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05579925, "A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05579925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*